Longview Acquisition Corp. II (LGV)
Price:
10.09 USD
( - 0 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Lucid Group, Inc.
VALUE SCORE:
0
2nd position
Jackson Acquisition Company II
VALUE SCORE:
8
The best
Jackson Acquisition Company II
VALUE SCORE:
8
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.
NEWS

HeartFlow, Longview Acquisition SPAC Deal Called Off
benzinga.com
2022-02-07 06:00:49HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that would have taken the cardiac test company public. HeartFlow described the move as a mutual decision a "result of current unfavorable market conditions.

Heartflow Charts NYSE Debut IPO Via $2.4B SPAC Deal
benzinga.com
2021-07-16 12:30:21Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview Acquisition Corp II (NYSE: LGV). Once the deal, valued at an enterprise value of about $2.4 billion, is complete, the resulting public company will operate under HeartFlow's banner with the NYSE ticker HFLO.
No data to display

HeartFlow, Longview Acquisition SPAC Deal Called Off
benzinga.com
2022-02-07 06:00:49HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that would have taken the cardiac test company public. HeartFlow described the move as a mutual decision a "result of current unfavorable market conditions.

Heartflow Charts NYSE Debut IPO Via $2.4B SPAC Deal
benzinga.com
2021-07-16 12:30:21Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview Acquisition Corp II (NYSE: LGV). Once the deal, valued at an enterprise value of about $2.4 billion, is complete, the resulting public company will operate under HeartFlow's banner with the NYSE ticker HFLO.